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Available online 11 April 2019At least one-third of all people with epilepsy have seizures that remain poorly controlled despite an increasing
number of available anti-epileptic drugs (AEDs). Often, there is an initial good response to a newly introduced
AED, which may last up to months, eventually followed by the return of seizures thought to be due to the
development of tolerance. We introduce a framework within which the interplay between AED response
and brain networks can be explored to understand the development of tolerance. We use a computer
model for seizure generation in the context of dynamic networks, which allows us to generate an ‘in silico’
electroencephalogram (EEG). This allows us to study the effect of changes in excitability network structure
and intrinsic model properties on the overall seizure likelihood. Within this framework, tolerance to AEDs –
return of seizure-like activity – may occur in 3 different scenarios: 1) the efﬁcacy of the drug diminishes
while the brain network remains relatively constant; 2) the efﬁcacy of the drug remains constant, but con-
nections between brain regions change; 3) the efﬁcacy of the drug remains constant, but the intrinsic excit-
ability within brain regions varies dynamically. We argue that these latter scenarios may contribute to a
deeper understanding of how drug resistance to AEDs may occur.niversity of Exe
an).
. This is an open© 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Prognosis1. Introduction
Epilepsy is a serious brain disorder with a lifetime incidence of
around 1%. One of the many challenges for neurologists treating epi-
lepsy is that at least one-third of all patients have seizures that remain
poorly controlled despite the increasing number of anti-epileptic
drugs (AEDs) now available, so-called drug-resistant epilepsy (DRE).
This number has remained frustratingly static, with no signiﬁcant im-
provement over the past 30 years [1]. An intriguing phenomenon is
termed tolerance, or the ‘honeymoon effect’, where after an initial
good response to a newly introduced medication, seizures return to
the previous frequency after a period of weeks ormonths. The phenom-
enon is most often described with benzodiazepines but is recognized to
affect most, if not all, AEDs [2–4]. Several mechanisms have been pro-
posed to explain this phenomenon, including metabolic (pharmacoki-
netic) tolerance, due to induction of AED-metabolizing enzymes or
blood–brain-barrier multidrug transporter proteins, and functional
(pharmacodynamic) tolerance, related to alteration of AED targetster, Exeter EX4
access article underthrough loss of receptor sensitivity or similar mechanisms [4,5]. There
is a good deal of evidence, both clinical and experimental, regarding
thesemechanisms, but none satisfactorily explains clinical observations
regarding the development of tolerance. Viewing the concept of toler-
ance more holistically, in particular to incorporate disease-related
mechanisms, may enable us to reconcile these common clinical obser-
vations [3]. Towards this aim,we consider the role that neural plasticity,
particularly at the level of large-scale brain networks, might play.
In recent years, our understanding of the role that the topology of
large-scale brain networks plays in shaping neuropathology has greatly
advanced [6]. In the case of epilepsy, it has been shown both conceptu-
ally and using clinical EEG in the case of generalized seizures that
perturbations to large-scale network structures, or to dynamics within
localized brain regions, can both lead to seizure activity [7,8]. In this
brief communication, we consider conceptually the interplay between
AED effects, brain network structures, and localized dynamics to
describe candidate mechanisms by which tolerance could emerge over
a timescale of months.
2. Methods
A dynamic network model was used to simulate networks of six
interconnected brain regions with asymmetric directed connectionsthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
265W. Woldman et al. / Epilepsy & Behavior 94 (2019) 264–268between them. Themodel is constructed as follows. Our starting point is
an equation previously introduced in the context of epilepsy [9]:
z0 ¼ f zð Þ þ αdw 0 ¼ λ−1þ iωð Þzþ 2z z2 −z z4 þ αdw 0 ð1Þ
This is a stochastic differential equation and is used to describe the
dynamics within a single brain region. Such an equation describes the
evolution over time of a variable z, whose output may be thought of as
a proxy for the electrographic activity recorded within a single channel
of EEG overlying that brain region. This equationwas chosen as it allows
two different types of dynamic behavior to simultaneously coexist. One
is a low-amplitude steady-state solution (that we consider a character-
istic of interictal brain states). The other is a high-amplitude oscillatory
state (characteristic of ictal brain activity) [10]. This simpliﬁed descrip-
tion serves as a proxy for the brain as it transitions from nonseizure to
seizure states and back again.
The parameter ω determines the frequency of oscillation. An appro-
priate choice ensures that the output oscillates around three cycles per
second (similar to the frequency seen during seizure activity). dw is a
noise term that has an amplitude deﬁned by α. Depending on the size
of the perturbation delivered by the noise term at each instance in
time, it is possible to transition from one dynamic state (e.g., the
interictal state) to the other (e.g., the seizure-like state), see Fig. 1.
This noise term is included to account for the multitude of dynamic in-
puts each brain region will receive that are not captured explicitly by
the dynamic Eq. (1).
The variable λ effectively controls the likelihood of transitioning
between the interictal and ictal states within a brain region, effectively
how ‘excitable’ each brain region is, and is deﬁned by the following
ordinary differential equation:
τλ0 ¼ λbaseline−λ− zj j−λAED
The overall transition likelihood depends on a ﬁxed parameter for
the system λbaseline, which is inhibited by the overall level of excitability
λ, the activity in the system |z |, and the effect of the AED (λAED). AFig. 1. Illustrating the different types of behavior of the system. Dynamics of the systemwill na
which is deﬁned by the term (λ− 1 + iω)z in the equation) or the high-amplitude oscillatory
equation). However, remaining in the same state is critically dependent on perturbations from
(interictal) state, the system will be slightly perturbed for small noise (bottom left). However,
amplitude of noisy perturbations received by the system is strong enough to drive the behavio
deﬁnes a boundary between the two different states: only if the noise perturbation is large e
term 2z|z|2 in the equation).system with low baseline level of excitability (λbaseline close to 0) can
be thought of as a ‘normal’ brain region whereas a region with λbaseline
close to 1 can be thought of as strongly ictogenic. Note that the effect
of the AED is modeled within the range λAED ∈ [0,1], which effectively
reduces the excitability of a region,making the transition to ictal activity
less likely. In this representation, we do not ascribe any neurobiological
mechanism to the reduction in excitability elicited by the AED, rather,
we think phenomenologically of the desired effect of an AED being to
reduce the level of emergent ‘excitability’ within a brain region. As
shown in Fig. 1, the onset of a seizure in this model critically depends
on the speciﬁc choice of parameters, most notably λbaseline and α.
If λbaseline is close to 0, only a large value for α would drive the system
towards the ictal state whereas if λbaseline is close to 1, even small values
ofαwould be enough to drive the system into a seizure. τ is a given time
constant, which effectively determines the duration of a seizure. Typical
values of parameters and variables are presented in Table 1.
It is important to reiterate that this is a purely phenomenological de-
scription that aims to describe the theoretical phenomenon of a transi-
tion into the seizure state; thismeans that amodel simulation replicates
at a conceptual level the fundamental components of the transition into
a seizure but does not have the same richness and level of detail as an
actual recording of a seizure. This is much in the way that an animal
model typically presents a phenotype that may be related to the
human condition but is, of course, not a substitute thereof.
We can extend these equations for a single region into a network
of coupled regions, where the dynamics of each region would corre-
spond to the activity captured by an EEG channel overlying that
region. The consequent “dynamic network model” consists of
coupling together N such regions (whose topology or structure is
deﬁned by the adjacency matrix A – effectively a set of ‘0’s and ‘1’s
where ‘1’ indicates a connection between two regions), with the
dynamics of region i described by:
zi 0 ¼ f zið Þ þ β
XN
j≠i
Aji zi−z j
 
0
@
1
Aþ αdwi tð Þ0:turally settle into the low-amplitude state (bottom right representing interictal dynamics,
state (top right representing ictal dynamics, which is deﬁned by the term−z|z|4 in the
the noise term being relatively small. If we assume we are initially in the low-amplitude
for increasing values of the noise term α (reﬂected by 0.01, 0.1, and 0.2), eventually, the
r into the high-amplitude oscillatory (ictal) state. The dotted line in the ﬁgure effectively
nough to cross this boundary can a seizure to occur in our model (this is deﬁned by the
Table 1
Description of model variables, parameters, and components.
Variable Description Dimension
z(t) = x(t) + iy(t) Complex state variable 2
λ(t) Excitability of a brain region 1
w(t) Complex Wiener process (a stochastic
process known as Brownian Motion)
2
Parameter Interpretation Typical values
ω Frequency of limit cycle 20 (rad/s)
α Noise amplitude 0.0535
τ Typical duration of return to excitability—baseline 50 (s)
λbaseline Baseline level of excitability of a brain region 0.60
λAED Effect of AED on the overall excitability of a brain
region
0.10
β Coupling strength 0.35
N Number of nodes in the network 6
A Adjacency matrix (N × N) [0,1]
Model component
(λ− 1 + iω)z Stable ﬁxed point: corresponding to an interictal resting-state
−z |z4| Stable ﬁxed point: corresponding to an oscillatory seizure-state
2z |z2| Unstable limit cycle: separates the two basins of attraction
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enological description, a connection between two regions is
“synchronizing”. This means that region i will inﬂuence region j to
exhibit the same dynamic state that it is in (e.g., interictal or ictal)
if there is a connection between regions i and j (due to the term
(zi − zj)). As a conceptual study, we do not attempt to ascribe any
underlying neurobiological context (e.g., an excitatory or inhibitory
process) to these connections; deﬁned by the matrix A, they representFig. 2. Illustrating 3 scenarios by which tolerance to antiepilepsy drugs might occur. In scenar
becomes less effective leading to the return of seizures. This corresponds to λAED = 0 at baseli
to λAED = 0.075 at 6 months as the efﬁcacy of the AED diminishes as ‘pharmacological’ toleran
scale brain networks could result in a situation where a drug ceases to be effective as the netw
ensure effective seizure control. In scenario 3, there is an alteration to a localized brain regio
this renders the same level of AED ineffective for seizure control. In scenarios B and C, we hav
3 and 6 months. In scenario B, the network structure changes by altering a single edge withi
Seizure recurrence then is a consequence of changes in the network structure or dynamics, ra
of the parameters; the system of Stochastic Differential Equation (SDEs) was solved using thean abstract representation of a brain and are not derived from imaging
data (e.g., EEG, magnetoencephalography (MEG), or functional mag-
netic resonance imaging (fMRI)). Herein, we consider a set of six inter-
connected brain regions as a pragmatic balance between complexity
and ease of illustration.
A critical determinant of level of inﬂuence is β, the global coupling
strength,whichdetermines the overall inﬂuence that connected regions
within the network can have on each other. Whether a transition to
seizure is observed is therefore dependent on the interplay between
the level of excitability and the intrinsic noise term within each brain
region and the synchronizing effect of other brain regions as a result
of the given connections within the network.
3. Results
The starting point for each scenario was a six-region network (see
Fig. 2), where the probability of interictal to ictal transition was signiﬁ-
cant (N1 Sz/week). For simplicity of analysis, parameters deﬁning
the brain dynamics within each node were identical, and similarly,
the strength of each formed connection was the same (see Table 1 for
parameter choices).
3.1. Scenario 1
The ﬁrst scenario we consider is designed to illustrate the classical
concept of the ‘honeymoon’ period (Fig. 2A). In this case, the adminis-
tration of the AED has an effect modeled as a reduction in the overall
level of excitability in each region. For the given brain network, the
effect of this reduction in excitability is to reduce the probability of a
transition from interictal to ictal dynamics to a negligible level. How-
ever, over time, the effect on excitability of the AED begins to wane,io A, the classical concept of a “honeymoon” period after which a prescribed medication
ne, λAED = 0.15 at 3 months (the time the new AED is ﬁrst administered), and decreased
ce develops, and seizure activity recurs. Scenario 2 considers how an alteration to large-
ork has become more “ictogenic” over time and so the same level of AED effect ceases to
n in such manner that it also increases the overall ictogenicity of a network. Once more,
e λAED = 0 at baseline and have maintained λAED = 0.15, the previously effective level, at
n the network, and in scenario C, the excitability of one node in the network is changed.
ther than through pharmacological tolerance developing. See Table 1 for all other choices
Euler–Maruyama method with a time step of 0.0001.
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probability of a transition to ictal dynamics becomes signiﬁcant, making
observation of a seizure likely.
3.2. Scenario 2
In the second scenario, we consider the role that neural plasticity, as
reﬂected in the evolution of large-scale network structures between
brain regions, may play (Fig. 2B). Again, we start from a network of
brain regions that supports regular transitions from interictal to ictal
dynamics. As before, if we consider that the initial administration of
the AED diminishes the overall excitability of the network, we see a
temporary absence of seizures in the model at 3 months. We then
examined the case where at some point between 3 and 6 months, the
network structure between brain regions has evolved subtly. In particu-
lar, we illustrate the case where a change in a single edge causes the
return of ictal dynamics after 6 months.
3.3. Scenario 3
In the ﬁnal scenario, we consider the role that neural plasticity, as
reﬂected in a change in internal dynamics within a brain region, may
play (Fig. 2C). In this case, we again start with a brain network that
supports regular transitions from interictal to ictal dynamics. In this
case, while the effect on overall excitability mediated by the AED
remains the same, and there is no alteration to the network structure,
over time, the internal excitability within a speciﬁc brain region
increases, such that the probability of transition from interictal to ictal
dynamics becomes signiﬁcant at six months, making observation of a
seizure more likely.
4. Discussion
Understanding the mechanisms of drug resistance is a necessary
step to develop strategies to mitigate this problem [11,12]. Characteriz-
ing the phenomenon of tolerance to AEDs has classically focused on
microscale mechanisms of drug (inter)actions in the brain, assuming
that the phenomenon of tolerance is associatedwith either a pharmaco-
kinetic or a pharmacodynamic effect [11]. Given that the brain is highly
plastic, it is therefore likely that epilepsy is an evolving process. Epilepsy
is nowwidely accepted to be a network disorder, and seizure generation
critically involves large-scale brain networks [13]. How mechanisms
across these different scales interact, and how likely seizures are to
occur as a result, remain open questions. Our study provides a different
perspective on the development of tolerance, which often leads to DRE,
suggesting that this phenomenonmay beunderstood as amanifestation
of adaptive network changes [14,15].
Within this framework, we assume that the action of an AED at the
macroscopic level is to reduce the level of excitability within brain
regions. We present three scenarios by which tolerance to AEDs can
occur. The ﬁrst assumes that a brain network remains relatively static
over time while the efﬁcacy of the drug diminishes. This scenario can
be thought of as the classical case: drug efﬁcacy diminishes because of
some unknown (presumed microscale) mechanism, and increased ex-
citability of the brain leads to the return of recurrent seizures. However,
we further describe two other scenarios where seizures can recur. In
both cases, there is no change to the efﬁcacy of the drug, rather, proper-
ties of the large-scale brain network evolve dynamically over time. One
case explores alterations to connections between brain regions, as we
might expect from neuroplasticity [16,17]. The second considers the
scenario where intrinsic excitability within brain regions varies dynam-
ically. This latter scenario may go some way towards explaining the
phenomenon of ﬂuctuating response, where a signiﬁcant minority of
people with epilepsy (~15%) experience long periods of seizure free-
dom interspersed with time windows, in the order of months, where
seizures are ongoing [1]. It is important to point out that this is not anexhaustive list of potential scenarios, indeed, there could be several
others, notably combinations of the scenarios we have considered
occurring simultaneously. Ultimately, further studies using neurophys-
iological and electrophysiological recordings from people with epilepsy
who actually experienced the honeymoon effect would allow for robust
testing of these scenarios, as well for further research on the underlying
mechanisms responsible for the observed honeymoon effect.
Such future studies focused on understanding how functional repre-
sentations of brain networks (either from EEG or fMRI) vary over time
may play a critical role in improving our clinical understanding of
the relative contribution of microscopic and macroscopic variables in
seizure generation and therefore the overall response to AEDs. For
example, long-term EEG monitoring could enable the identiﬁcation of
changes in network structure or model properties related to changes
in medication or dosage. To date, recordings of sufﬁcient duration
to capture changes of this nature have not been available to study
changes in the dynamics of brain activity over the long periods neces-
sary but will likely soon be possible, for example using subscalp
electrodes [18,19]. These studies ultimately may have prognostic
value: revealing patient-speciﬁc features of drug efﬁcacy that enable
an optimal treatment regime.
Acknowledgments and disclosure of conﬂict of interest
Wessel Woldman received ﬁnancial support from the Medical
Research Council (via MR/N01524X/1). John R. Terry and Mark Cook
received ﬁnancial support from a Royal Society International Exchanges
Award (grant number IE170112). John R. Terry further acknowledges
the generous support of the Wellcome Trust Institutional Strategic
Support Award (WT105618MA), and the EPSRC (via Centre Grant EP/
N014391/1). We have no conﬂict of interest to declare. We conﬁrm
that we have read the Journal's position on issues involved in ethical
publication and afﬁrm that this report is consistent with those guide-
lines. FullMatlab scriptswill bemade available on an appropriate repos-
itory (e.g., GitHub).
References
[1] Brodie MJ, Barry SJE, Bamagous GA, Norrie JD, Kwan P. Patterns of treatment
response in newly diagnosed epilepsy. Neurology 2012;78:1548–54.
[2] Löscher W, Potschka H. Drug resistance in brain diseases and the role of drug efﬂux
transporters. Nat Rev Neurosci 2005;6:591–602.
[3] Schmidt D, Löscher W. Drug resistance in epilepsy: putative neurobiologic and
clinical mechanisms. Epilepsia 2005;46:858–77.
[4] Margineanu DG, Klitgaard H. Mechanisms of drug resistance in epilepsy: relevance
for antiepileptic drug discovery. Expert Opin Drug Discovery 2009;4:23–32.
[5] Löscher W, Schmidt D. Experimental and clinical evidence for loss of effect
(tolerance) during prolonged treatment with antiepileptic drugs. Epilepsia 2006;
47:1253–84.
[6] Fornito A, Zalesky A, Breakspear M. The connectomics of brain disorders. Nat Rev
Neurosci 2015;16:159–72.
[7] Terry JR, Benjamin O, Richardson MP. Seizure generation: the role of nodes and
networks. Epilepsia 2012;53:e166–9.
[8] Schmidt H, Woldman W, Goodfellow M, Chowdhury FA, Koutroumanidis M, Jewell
S, et al. A computational biomarker of idiopathic generalized epilepsy from
resting-state EEG. Epilepsia 2016;57:e200–4.
[9] Kalitzin SN, Velis DN, Lopes da Silva FH. Stimulation-based anticipation and control
of state transitions in the epileptic brain. Epilepsy Behav 2010;17:310–23.
[10] Benjamin O, Fitzgerald TH, Ashwin P, Tsaneva-Atanasova K, Chowdhury F,
Richardson MP, et al. A phenomenological model of seizure initiation suggests net-
work structure may explain seizure frequency in idiopathic generalised epilepsy.
J Math Neurosci 2012;2:1.
[11] Kwan P, Schachter SC, Brodie MJ. Drug-resistant epilepsy. N Engl J Med 2011;365:
919–26.
[12] Widdess-Walsh P, Devinsky O. Antiepileptic drug resistance and tolerance in
epilepsy. Rev Neurol Dis 2007;4:194–202.
[13] Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, et al. Operational clas-
siﬁcation of seizure types by the International League Against Epilepsy: position
paper of the ILAE Commission for Classiﬁcation and Terminology. Epilepsia 2017;
58:522–30.
[14] Berg AT, Langﬁtt J, Shinnar S, Vickrey BG, Sperling MR, Walczak T, et al. How long
does it take for partial epilepsy to become intractable? Neurology 2003;60:186–90.
[15] Berg AT, Vickrey BG, Testa FM, Levy SR, Shinnar S, DiMario F, et al. How long does it
take for epilepsy to become intractable? A prospective investigation. Ann Neurol
2006;60:73–9.
268 W. Woldman et al. / Epilepsy & Behavior 94 (2019) 264–268[16] Mana MJ, Kim CK, Pinel JP, Jones CH. Contingent tolerance to the anticonvulsant
effects of carbamazepine, diazepam, and sodiumvalproate in kindled rats. Pharmacol
Biochem Behav 1992;41:121–6.
[17] Mana MJ, Kim CK, Pinel JP. Tolerance to the anticonvulsant effects of carbamazepine,
diazepam, and sodium valproate in kindled rats. Pharmacol Biochem Behav 1992;
41:109–13.[18] Benovitski YB, Lai A, McGowan CC, Burns O, Maxim V, Nayagam DAX, et al. Ring
and peg electrodes for minimally-invasive and long-term sub-scalp EEG recordings.
Epilepsy Res 2017;135:29–37.
[19] Weisdorf S, Gangstad SW, Duun-Henriksen J, Mosholt KS, Kjær TW. High similarity
between EEG from subcutaneous and proximate scalp electrodes in patients with
temporal lobe epilepsy. J Neurophysiol 2018;120(3):1451–60.
